From: MomsTalkShots, tailored educational app, improves vaccine attitudes: a randomized controlled trial
% with above average construct scoresc among those not receiving MomsTalkShots | % with above average construct scoresc among those receiving MomsTalkShots | Effect of MomsTalkShots on % with above average construct scoresc, OR (95% CI)b | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Intentions to Vaccinatea | All | Yes | No | Unsure | All | Yes | No | Unsure | All | Yes | No | Unsure |
KAB Constructs c | ||||||||||||
Specific safety concerns (for infant vaccines)fh | 56 | 49 | 90 | 89 | 53 | 47 | 87 | 81 | 0.89 (0.70–1.12) | 0.94 (0.73–1.20) | 0.62 (0.19–2.05) | 0.44 (0.14–1.40) |
Perceived risk (maternal influenza)d | 55 | 64 | 32 | 42 | 61 | 71 | 38 | 44 | 1.61 (1.23–2.09) | 1.57 (1.12–2.20) | 2.07 (1.15–3.71) | 1.53 (0.70–3.34) |
Confidence in vaccine efficacy (maternal influenza vaccine)d | 63 | 77 | 28 | 39 | 73 | 86 | 44 | 52 | 1.97 (1.47–2.65) | 2.09 (1.36–3.22) | 2.62 (1.46–4.69) | 1.96 (0.90–4.26) |
Perceived risk (infant whooping cough)f | 42 | 47 | 22 | 19 | 39 | 42 | 19 | 31 | 0.75 (0.57–1.00)g | 0.70 (0.51–0.96) | 0.77 (0.27–2.24) | 2.18 (0.68–6.96) |
Confidence in vaccine efficacy (whooping cough vaccine)e | 56 | 68 | 24 | 47 | 61 | 72 | 37 | 41 | 1.01 (0.77–1.33) | 0.96 (0.69–1.34) | 1.42 (0.71–2.86) | 0.53 (0.18–1.52 |
Pro-vaccine social normsf | 44 | 49 | 19 | 15 | 46 | 51 | 15 | 33 | 1.08 (0.86–1.35) | 1.05 (0.83–1.34) | 0.55 (0.20–1.47) | 2.57 (0.97–6.85) |
Perceived vaccine knowledgef | 48 | 53 | 24 | 28 | 55 | 59 | 38 | 33 | 1.39 (1.13–1.72) | 1.36 (1.08–1.70) | 2.04 (0.97–4.28) | 1.00 (0.41–2.45) |
Trust in vaccine information (from obstetricians and pediatricians)f | 53 | 60 | 23 | 20 | 59 | 27 | 26 | 27 | 1.22 (0.97–1.54) | 1.22 (0.95–1.56) | 1.43 (0.63–3.27) | 1.12 (0.43–2.93) |
Trust in vaccine information (from naturopaths and chiropractors)f | 56 | 57 | 60 | 51 | 60 | 61 | 59 | 51 | 0.83 (0.57–1.19) | 0.76 (0.50–1.16) | 1.04 (0.33–3.30) | 0.83 (0.26–2.61) |
Trust in vaccine information (from federal agencies and academic institutions)f | 48 | 55 | 18 | 13 | 49 | 55 | 14 | 25 | 1.06 (0.84–1.34) | 1.02 (0.79–1.31) | 0.77 (0.29–2.06) | 1.88 (0.65–5.47) |